Grown Rogue International (GRUSF) Capital Expenditures (2018 - 2026)

Grown Rogue International's (GRUSF) quarterly Capital Expenditures came in at $2.5 million in Q1 2026, up 942.27% year-on-year from $241532.0 in Q1 2025, and down 100.0% quarter-over-quarter from $1056.5 billion in Q4 2025.

Grown Rogue International (GRUSF) Capital Expenditures (2018 - 2026) Analysis & Trends

Grown Rogue International's Capital Expenditures history runs 9 years deep, the most recent figure standing at $2.5 million for Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 942.27% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $6.9 million, a 50.07% increase from a year earlier, with the FY2025 full-year figure at $4.7 million, up 14.13% from the prior year.
  • Capital Expenditures declined to $2.5 million in Q1 2026 per GRUSF's latest filing, from $1056.5 billion in the prior quarter.
  • Across five years, Capital Expenditures topped out at $1267.5 billion in Q4 2024 and bottomed at -$1267.5 billion in Q3 2024.
  • The 5-year median for Capital Expenditures is -$297314.0 (2024), against an average of $548372.8.
  • Across the five-year window, Capital Expenditures slumped 261.34% in 2022 and jumped 1000503556.29% in 2024, its largest moves.
  • Year by year, Capital Expenditures stood at -$574595.0 in 2022, then surged by 122.05% to $126690.0 in 2023, then soared by 1000503556.29% to $1267.5 billion in 2024, then declined by 16.65% to $1056.5 billion in 2025, then tumbled by 100.0% to $2.5 million in 2026.
  • Per Business Quant, the three latest GRUSF Capital Expenditures figures stand at $2.5 million (Q1 2026), $1056.5 billion (Q4 2025), and -$1056.5 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 168.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 99.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 51.00 Mn
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn 2.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.52 Mn
Mar 31, 2026 2.52 Mn
Dec 31, 2025 1,056.50 Bn
Dec 31, 2025 1,056.50 Bn
Sep 30, 2025 -1,056.50 Bn
Sep 30, 2025 -1,056.50 Bn
Jun 30, 2025 -773,726.00
Jun 30, 2025 -773,726.00
Mar 31, 2025 241,532.00
Mar 31, 2025 241,532.00
Dec 31, 2024 1,267.54 Bn
Dec 31, 2024 1,267.54 Bn
Sep 30, 2024 -1,267.53 Bn
Sep 30, 2024 -1,267.53 Bn
Jun 30, 2024 -230,497.00
Jun 30, 2024 -230,497.00
Mar 31, 2024 -297,314.00
Mar 31, 2024 -297,314.00
Dec 31, 2023 126,690.00
Dec 31, 2023 126,690.00